Yang, S., Peng, L. R., Yu, A. Q., & Li, J. (2023). CSNK2A2 promotes hepatocellular carcinoma progression through activation of NF-κB pathway. Elsevier.
Chicago Style (17th ed.) CitationYang, Shuang, Li Rong Peng, Ai Qing Yu, and Jiang Li. CSNK2A2 Promotes Hepatocellular Carcinoma Progression Through Activation of NF-κB Pathway. Elsevier, 2023.
MLA (9th ed.) CitationYang, Shuang, et al. CSNK2A2 Promotes Hepatocellular Carcinoma Progression Through Activation of NF-κB Pathway. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.